(Q38287518)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25504149%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

review article

1 reference

title

Glioblastoma stem-like cells: at the root of tumor recurrence and a therapeutic target (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25504149%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25504149%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

author name string

Melanie Jackson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25504149%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

Foteini Hassiotou

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25504149%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

language of work or name

English

0 references

publication date

11 December 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25504149%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25504149%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

volume

36

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25504149%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25504149%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

page(s)

177-185

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25504149%20AND%20SRC:MED&resulttype=core&format=json

Clinical management and survival outcomes of gliosarcomas in the era of multimodality therapy

25 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

A multigene predictor of outcome in glioblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

The somatic genomic landscape of glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Malignant glioma: lessons from genomics, mouse models, and stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Inhibition of EGFR induces a c-MET-driven stem cell population in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

MGMT gene silencing and benefit from temozolomide in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Predictive biomarkers in adult gliomas: the present and the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

CD133(+) and CD133(-) glioblastoma-derived cancer stem cells show differential growth characteristics and molecular profiles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Exploration of the gene fusion landscape of glioblastoma using transcriptome sequencing and copy number data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

The clonal evolution of tumor cell populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

The therapeutic promise of the cancer stem cell concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Cancer stem cells: mirage or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Acquired cancer stem cell phenotypes through Oct4-mediated dedifferentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

A restricted cell population propagates glioblastoma growth after chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

The role of cancer stem cells in breast cancer initiation and progression: potential cancer stem cell-directed therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Coexistence of quiescent and active adult stem cells in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Tumour heterogeneity and cancer cell plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Identification of human brain tumour initiating cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Unique astrocyte ribbon in adult human brain contains neural stem cells but lacks chain migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Subventricular zone astrocytes are neural stem cells in the adult mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Mesenchymal differentiation of glioblastoma stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Know thy neighbor: stromal cells can contribute oncogenic signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

The stem-cell niche as an entity of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Socializing with the neighbors: stem cells and their niche

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Relationship of glioblastoma multiforme to neural stem cell regions predicts invasive and multifocal tumor phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Mosaic analysis with double markers reveals tumor cell of origin in glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Distinct pools of cancer stem-like cells coexist within human glioblastomas and display different tumorigenicity and independent genomic evolution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

A perivascular niche for brain tumor stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Glioma-associated stem cells: a novel class of tumor-supporting cells able to predict prognosis of human low-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Stem cell-like glioma cells promote tumor angiogenesis through vascular endothelial growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Transcriptional profiles of CD133+ and CD133- glioblastoma-derived cancer stem cell lines suggest different cells of origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Stem cell marker CD133 affects clinical outcome in glioma patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

CD133 identifies perivascular niches in grade II-IV astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Id-1 is a key transcriptional regulator of glioblastoma aggressiveness and a novel therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Prospective identification of tumorigenic breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Identification of pancreatic cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

A role for Id proteins in mammary gland physiology and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

L1 expression as a marker for poor prognosis, tumor progression, and short survival in patients with colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Targeting cancer stem cells through L1CAM suppresses glioma growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

The MET oncogene in glioblastoma stem cells: implications as a diagnostic marker and a therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

MET signaling regulates glioblastoma stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

c-Met signaling induces a reprogramming network and supports the glioblastoma stem-like phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

The MET oncogene is a functional marker of a glioblastoma stem cell subtype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Targeting a glioblastoma cancer stem-cell population defined by EGF receptor variant III.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

EGFRvIII-targeted vaccination therapy of malignant glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Expression profile of embryonic stem cell-associated genes Oct4, Sox2 and Nanog in human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Core transcriptional regulatory circuitry in human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

A mesenchymal glioma stem cell profile is related to clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

EGFR-STAT3 signaling promotes formation of malignant peripheral nerve sheath tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

STAT3 Activation in Glioblastoma: Biochemical and Therapeutic Implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

The transcriptional network for mesenchymal transformation of brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

LLL-3 inhibits STAT3 activity, suppresses glioblastoma cell growth and prolongs survival in a mouse glioblastoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Association of reactive oxygen species levels and radioresistance in cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Glioma stem cells promote radioresistance by preferential activation of the DNA damage response

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Therapeutic approaches to target cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Normal and malignant epithelial cells with stem-like properties have an extended G2 cell cycle phase that is associated with apoptotic resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Hypoxia--a key regulatory factor in tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

CD133 is a marker of bioenergetic stress in human glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Anti-cancer Therapies in High Grade Gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Genetic profile of gliosarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Amplification of the STOML3, FREM2, and LHFP genes is associated with mesenchymal differentiation in gliosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Transcriptional factors for epithelial-mesenchymal transition are associated with mesenchymal differentiation in gliosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Molecular pathogenesis of osteosarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Multilineage potential of adult human mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Novel epigenetic mechanisms that control pluripotency and quiescence of adult bone marrow-derived Oct4(+) very small embryonic-like stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Expression of an exogenous human Oct-4 promoter identifies tumor-initiating cells in osteosarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Recruited brain tumor-derived mesenchymal stem cells contribute to brain tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Cell fusion-independent differentiation of neural stem cells to the endothelial lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Embryonic stem cells markers SOX2, OCT4 and Nanog expression and their correlations with epithelial-mesenchymal transition in nasopharyngeal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Targeted silencing of the oncogenic transcription factor SOX2 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Novel role of Engrailed 1 as a prosurvival transcription factor in basal-like breast cancer and engineering of interference peptides block its oncogenic function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

Cancer: The root of the problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCARCIN%2FBGU243

21 January 2018

Identifiers

DOI

10.1093/CARCIN/BGU243

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25504149%20AND%20SRC:MED&resulttype=core&format=json

25 February 2020

1 reference